Portfolio company
Teneobio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This clinical-stage biotechnology company develops human heavy-chain antibodies and multispecific biologics to treat patients with cancers, autoimmune disorders and infectious diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Candid Therapeutics
This clinical-stage biotechnology company develops T-cell engager antibodies for patients with autoimmune and inflammatory diseases.
Tentarix Biotherapeutics, LP
This biotechnology company develops conditionally active multispecific biologics for pharmaceutical partners to treat oncology and autoimmune diseases.
Radiant Biotherapeutics
This company develops multi-specific antibody therapies to treat patients with cancer and infectious diseases.
VelaVigo
This biotechnology company develops multi-specific antibodies and antibody-drug conjugates for patients with cancer and autoimmune diseases.
Hummingbird Bioscience
This company develops antibody-based therapeutics and drug conjugates for patients with hard-to-treat cancers and autoimmune diseases.
Belenos Biosciences
This clinical-stage biotechnology company develops long-acting bispecific antibody therapeutics for patients with chronic inflammatory diseases such as asthma and atopic dermatitis.
Ancora Biotech
The company develops multi-specific antibody therapeutics to treat patients with cancer, inflammatory disorders, and chronic hepatitis B infections.
Granite Bio
This clinical-stage biotechnology company develops therapeutic antibodies to treat patients with inflammatory, autoimmune and fibrotic diseases.
